anonymous
Guest
anonymous
Guest
Eisai's Leqembi rollout moves slower than expected
Eisai, Biogen likely to miss early launch goal for Alzheimer's drug Leqembi
Eisai, Biogen likely to miss early launch goal for Alzheimer's drug Leqembi